EMCDDA insights 6 - An overview of cannabis potency in Europe

被引：0
作者：
Solowij, N [1 ]
机构：
[1] Univ Wollongong, Dept Psychol, Illawarra Inst Mental Hlth, Neurosci Inst Schizophrenia & Allied Disorders, Wollongong, NSW 2522, Australia
来源：
DRUG AND ALCOHOL REVIEW | 2005年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：291 / 293
页数：3
相关论文
共 6 条
  • [1] [Anonymous], 2002, J PALLIAT CARE
  • [2] ElSohly MA, 2000, J FORENSIC SCI, V45, P24
  • [3] ELSOHLY MA, 1999, 69 U MISS NAT CTR DE
  • [4] *EUR MON CTR DRUGS, 2004, OV CANN POT EUR
  • [5] The THC content of cannabis in Australia: evidence and implications
    Hall, W
    Swift, W
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2000, 24 (05) : 503 - 508
  • [6] Cannabis use and psychotic disorders: an update
    Hall, W
    Degenhardt, L
    Teesson, M
    [J]. DRUG AND ALCOHOL REVIEW, 2004, 23 (04) : 433 - 443
1